Join Doctors Without Borders/Médecins Sans Frontières (MSF) and New York Times science writer Denise Grady for an online panel discussion on the global crisis of drug-resistant tuberculosis (DR-TB). The panel, comprised of health care workers and patient advocates working to improve treatment for people living with DR-TB, featuring Dr. Grania Brigden, TB advisor, MSF Access Campaign; Cathy Hewison, TB medical advisor at MSF; Mark Harrington, executive director of the Treatment Action Group; and Evaline Kibuchi, Senior TB advocacy manager at the Kenya AIDS NGO Consortium (KANCO).
Tuberculosis (TB) is more prevalent in Buenaventura, one of Columbia's biggest port cities, than anywhere else in the country. Doctors Without Borders/Médecins Sans Frontières (MSF) is working there because many people in urgent need of TB treatment have difficulty accessing the healthcare system. More than 300 TB and drug-resistant TB patients were admitted to the program in 2012.
The first new drug approved to treat tuberculosis (TB) since 1963 could result in shorter treatment with less side effects and the opportunity to treat more people. For people with drug-resistant TB, it could present a new lifeline.
The January 2013 Month In Focus features brief reports on the following Doctors Without Borders/Médecins Sans Frontières (MSF) activities: assisting destitute civilians in Syria; a positive report on treatment of tuberculosis; an international conference in New York on fatally neglected diseases; monitoring the situation in Yida refugee camp in South Sudan; and preventing a measles epidemic among displaced children in the Democratic Republic of Congo.
After years of conflict, a large number of tuberculosis (TB) cases are now being diagnosed in Chechnya. Half are drug-resistant cases. To help ensure that patients adhere to treatment, Doctors Without Borders/Médecins Sans Frontières (MSF) has set up a counseling program which is an integral part of the treatment.
In northwestern Uzbekistan, drug-resistant forms of tuberculosis (TB) are spreading while only one in 10 people with TB receives treatment. Doctors Without Borders/Médecins Sans Frontières (MSF) has treated more than 2,000 people with drug-resistant TB in Uzbekistan over the last 10 years.
Her coffin had already been built when Rohatay TagsAbdullaeva learned she could get help in her native Uzbekistan. As World TB Day approaches, MSF celebrates her good health, but also remembers the huge number of people with TB who cannot get the help they need.
New research is showing that there are clear benefits of having HIV patients start antiretroviral treatment before their immune system drops to very low levels. There is less risk of them developing co-infections, such as tuberculosis, and hospitals will receive fewer severely ill patients. In this five-part video series, MSF demonstrates tools and models that could help make improved treatment accessible to many more. Between June 8 and 10, 2011, world leaders will meet in New York to decide on the future of the millions needing treatment urgently. By sharing this video, help us spread the word that there is NO EXCUSE for governments to leave 10 million people untreated! See www.doctorswithoutborders.org/stopthevirus for more info.